DF/HCC Program Affiliation

Outcomes Research
Palliative Care

Research Abstract

I am a medical oncologist whose main academic endeavor is research in clinical epidemiology and health services research in cancer. My research examines factors that are biologically separate from cancer but that may nonetheless be important determinants of its presentation, diagnosis, treatment, and mortality. In this research, I strive to be innovative in at least two broad ways: first, by focusing on non-malignant factors that affect malignant disease treatment and outcome, and second by privileging a life-course perspective in oncology, thus examining the full trajectory of cancer from screening for an illness to death.

Publications

• Yabroff KR, Davis WW, Lamont EB, Fahey A, Topor M, Brown ML, Warren JL.Patient time costs associated with cancer care.Journal of the National Cancer Institute 2007 Jan 3;99(1):14-23.
  17202109
• Lamont EB, Herndon JE, Weeks JC, Henderson IC, Earle CC, Schilsky RL, Christakis NA,.Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344).J Natl Cancer Inst 2006 Sep 20;98
  16985253
• Paskett ED, Schrag D, Kornblith A, Lamont EB, Weeks JC, Marshall JR, Shapiro C, Holland J.Cancer and leukemia group B cancer control and health outcomes committee: origins and accomplishments.Clin Cancer Res 2006 Jun 1;12(11 Pt 2):3601s-5s.
  16740792
• Lamont EB.A demographic and prognostic approach to defining the end of life.J Palliat Med 2005;8 Suppl 1:S12-21.
  16499460
• Polite BN, Lamont EB.Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly?: a case-control study of Medicare beneficiaries.Cancer 2006 Feb 15;106(4):923-30.
  16411227
• Lamont EB, Herndon JE, Weeks JC, Henderson IC, Lilenbaum R, Schilsky RL, Christakis NA.Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.J Natl Cancer Inst 2005 Jul 20;97(14):1080-3
  16030306
• Hotte SJ, Winquist EW, Lamont E, MacKenzie M, Vokes E, Chen EX, Brown S, Pond GR, Murgo A, Siu LL.Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study.J C
  15659505
• Gupta SK, Lamont EB.Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia.J Am Geriatr Soc 2004 Oct;52(10):1681-7.
  15450045
• Lamont EB, Lauderdale DS.Low risk of hip fracture among elderly breast cancer survivors.Ann Epidemiol 2003 Nov;13(10):698-703.
  14599734
• Lamont EB, Hayreh D, Pickett KE, Dignam JJ, List MA, Stenson KM, Haraf DJ, Brockstein BE, Sellergren SA, Vokes EE.Is patient travel distance associated with survival on phase II clinical trials in oncology?.J Natl Cancer Inst 2003 Sep 17;95(18):1370-5.
  13130112
• Lamont EB, Christakis NA.Complexities in prognostication in advanced cancer: "to help them live their lives the way they want to".JAMA 2003 Jul 2;290(1):98-104.
  12837717
• Lamont EB, Christakis NA, Lauderdale DS.Favorable cardiac risk among elderly breast carcinoma survivors.Cancer 2003 Jul 1;98(1):2-10.
  12833448
• Iwashyna TJ, Lamont EB.Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer.J Clin Oncol 2002 Oct 1;20(19):3992-8.
  12351596
• Lamont EB, Christakis NA.Physician factors in the timing of cancer patient referral to hospice palliative care.Cancer 2002 May 15;94(10):2733-7.
  12173344
• Lamont EB, Vokes EE.Chemotherapy in the management of squamous-cell carcinoma of the head and neck.Lancet Oncol 2001 May;2(5):261-9.
  11905780
• Lamont EB, Lauderdale DS, Schilsky RL, Christakis NA.Construct validity of medicare chemotherapy claims: the case of 5FU.Med Care 2002 Mar;40(3):201-11.
  11880793
• Lamont EB, Christakis NA.Prognostic disclosure to patients with cancer near the end of life.Ann Intern Med 2001 Jun 19;134(12):1096-105.
  11412049
• Christakis NA, Lamont EB.Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study.BMJ 2000 Feb 19;320(7233):469-72.
  10678857
• Lamont EB, Schilsky RL.The oral fluoropyrimidines in cancer chemotherapy.Clin Cancer Res 1999 Sep;5(9):2289-96.
  10499595
• Lamont EB, Christakis NA.Some elements of prognosis in terminal cancer.Oncology (Huntingt) 1999 Aug;13(8):1165-70; discussion 1172-.
  10499248